A new JCVI spinout, Diploid Genomics, launched with seed backing from Healthier Capital and plans to combine long‑read sequencing, imaging and AI models for discovery and diagnostics. Cofounders include J. Craig Venter, Gene Myers and Anders Dale; the company intends to build a sequencing center in San Diego and pursue CLIA certification for clinical‑grade outputs. Diploid aims to sell analytics to life‑science companies and health systems, leveraging PacBio and Oxford Nanopore platforms and advanced AI to integrate multimodal data. The launch reflects continued investor interest in AI‑powered genomics services and the commercialization of complex sequencing workflows.